One of the many advantages of a non-viral vector is that it is less toxic than the viral vectors. However, recent results from this and other labs have shown that plasmid DNA delivered systemically can induced an acute and systemic inflammatory response, which is dose limiting in some applications. High levels of pro-inflammatory cytokines, i.e. TNF-alpha, IL-6, IL-12 and gamma-INF, are detected in the serum of the injected mice few hours after the treatment. Besides the undesirable toxicity, high levels of cytokine production also decrease the extent and duration of gene expression in the target tissue. Most of the inflammatory activities come from the unmethylated CpG motifs, such as RRCGYY, in the plasmid DNA. The goal of this project is to investigate the relationship between DNA sequence and inflammation, with an ultimate hope to construct a plasmid vector that is substantially non-inflammatory and suitable to be used in non-viral gene therapy. In addition, the mechanism of action for these immunostimulating motifs will be studied. The project will be focused in the following four aims: (1) At least two oligonucleotides have been identified with a strong inhibitory activity. They contain sequences similar to the binding elements of two different transcriptional factors, NFKappaB and ETS-2. Since these elements are found in the upstream regulatory region of several cytokine genes, it is hypothesized that the oligonucleotides work as decoys to inhibit the transcriptional factors that are required for the expression of cytokines. We will look for additional decoy oligonucleotides along the same line of reasoning. (2) We will also investigate if the inhibitory motifs work as decoys for the transcriptional factors by performing gel shift and super shift assays. The transcriptional activity of several pro-inflammatory cytokine genes will be studied by Northern blot analysis and cDNA microarray. (3) The mechanism of action of the immunostimulating motifs will be studied. We will look for the putative binding protein(s) of RRCGYY by using yeast one hybrid cloning method. (4) We will construct a plasmid vector(s) with most, if not all, of the stimulating motifs mutated and with several inhibitory motifs added. The goal is to obtain a vector with much reduced inflammatory activity and suitable for use in non-viral gene therapy.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI048851-05
Application #
6837681
Study Section
Special Emphasis Panel (ZRG1-PC (01))
Program Officer
Gondre-Lewis, Timothy A
Project Start
2001-01-01
Project End
2005-07-31
Budget Start
2005-01-01
Budget End
2005-07-31
Support Year
5
Fiscal Year
2005
Total Cost
$12,854
Indirect Cost
Name
University of Pittsburgh
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Sha, Huizi; Zou, Zhengyun; Xin, Kai et al. (2015) Tumor-penetrating peptide fused EGFR single-domain antibody enhances cancer drug penetration into 3D multicellular spheroids and facilitates effective gastric cancer therapy. J Control Release 200:188-200
Chono, Sumio; Li, Shyh-Dar; Conwell, Christine C et al. (2008) An efficient and low immunostimulatory nanoparticle formulation for systemic siRNA delivery to the tumor. J Control Release 131:64-9
Liu, Feng; Conwell, Christine C; Yuan, Xing et al. (2007) Novel nonviral vectors target cellular signaling pathways: regulated gene expression and reduced toxicity. J Pharmacol Exp Ther 321:777-83
Li, S-D; Huang, L (2006) Gene therapy progress and prospects: non-viral gene therapy by systemic delivery. Gene Ther 13:1313-9
Vangasseri, Dileep P; Cui, Zhengrong; Chen, Weihsu et al. (2006) Immunostimulation of dendritic cells by cationic liposomes. Mol Membr Biol 23:385-95
Vangasseri, Dileep Padinjarae; Han, Su-Ji; Huang, Leaf (2005) Lipid-protamine-DNA-mediated antigen delivery. Curr Drug Deliv 2:401-6
Conwell, Christine C; Huang, Leaf (2005) Recent advances in non-viral gene delivery. Adv Genet 53:3-18
Chen, Weihsu Claire; Huang, Leaf (2005) Non-viral vector as vaccine carrier. Adv Genet 54:315-37
Cui, Zhengrong; Han, Su-Ji; Vangasseri, Dileep Padinjarae et al. (2005) Immunostimulation mechanism of LPD nanoparticle as a vaccine carrier. Mol Pharm 2:22-8
Cui, Zhengrong; Huang, Leaf (2005) Liposome-polycation-DNA (LPD) particle as a carrier and adjuvant for protein-based vaccines: therapeutic effect against cervical cancer. Cancer Immunol Immunother 54:1180-90

Showing the most recent 10 out of 26 publications